- Home
- RMR vs XOMA Comparison
RMR vs XOMA Comparison
Compare RMR & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMR
- XOMA
- Stock Information
- Founded
- RMR 1986
- XOMA 1981
- Country
- RMR United States
- XOMA United States
- Employees
- RMR N/A
- XOMA N/A
- Industry
- RMR Professional Services
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- RMR Consumer Discretionary
- XOMA Health Care
- Exchange
- RMR Nasdaq
- XOMA Nasdaq
- Market Cap
- RMR 347.9M
- XOMA 355.6M
- IPO Year
- RMR N/A
- XOMA N/A
- Fundamental
- Price
- RMR $19.76
- XOMA $26.76
- Analyst Decision
- RMR Buy
- XOMA Strong Buy
- Analyst Count
- RMR 2
- XOMA 2
- Target Price
- RMR $32.00
- XOMA $81.50
- AVG Volume (30 Days)
- RMR 117.6K
- XOMA 36.4K
- Earning Date
- RMR 02-05-2025
- XOMA 03-07-2025
- Dividend Yield
- RMR 9.11%
- XOMA N/A
- EPS Growth
- RMR N/A
- XOMA N/A
- EPS
- RMR 1.38
- XOMA N/A
- Revenue
- RMR $196,924,000.00
- XOMA $21,606,000.00
- Revenue This Year
- RMR $379.19
- XOMA $511.48
- Revenue Next Year
- RMR $2.01
- XOMA $26.91
- P/E Ratio
- RMR $14.32
- XOMA N/A
- Revenue Growth
- RMR N/A
- XOMA 389.82
- 52 Week Low
- RMR $19.08
- XOMA $18.57
- 52 Week High
- RMR $26.82
- XOMA $35.00
- Technical
- Relative Strength Index (RSI)
- RMR 36.55
- XOMA 47.49
- Support Level
- RMR $19.25
- XOMA $23.88
- Resistance Level
- RMR $20.00
- XOMA $29.02
- Average True Range (ATR)
- RMR 0.50
- XOMA 1.27
- MACD
- RMR 0.04
- XOMA 0.27
- Stochastic Oscillator
- RMR 35.98
- XOMA 56.03
About RMR The RMR Group Inc.
The RMR Group Inc is a holding company that conducts its business through its subsidiary, which is an alternative asset management company that invests in real estate and manages real estate-related businesses. Its business consists of providing management services to publicly owned real estate investment trusts, or REITs, and real estate-related operating companies. It also provides management services to real estate securities mutual funds and commercial real estate finance companies. The company's operating segment is RMR LLC and All Other Operations. The RMR Group derives its revenue from providing business and property management services as well as advisory and other services.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.